Mereo BioPharma Group plc (MREO) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -4.31M | -7.68M | -7.31M | -7.65M | -8.33M | -9.42M | -7.52M | -7.9M | -7.99M | -6.79M | 2.66M | -7.75M |
| Operating CF Margin % | - | - | - | -1530.2% | - | - | - | - | - | -678.9% | 498.47% | -86.16% |
| Operating CF Growth % | 48.23% | 18.45% | 2.79% | 3.2% | -4.23% | -38.75% | -382.78% | -1.93% | 13.59% | 67.07% | 119.08% | 67.9% |
| Net Income | -6.72M | -7.35M | -7.02M | -14.62M | -12.89M | -7.05M | -15M | -12.26M | -8.95M | -9.11M | -6.53M | -1.75M |
| Depreciation & Amortization | 171K | 722K | -11K | 298K | 270K | 274K | 282K | 257K | 275K | 281K | 282K | 271K |
| Stock-Based Compensation | 1.6M | 1.54M | 0 | 2.06M | 2.28M | 1.51M | 1.74M | 2.09M | 2.05M | 815K | 1.53M | 943K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -1.53M | -345.96K | -910K | 5.45M | 2.52M | -5.02M | 6.84M | 586K | 141K | 3.33M | -1.79M | -495K |
| Working Capital Changes | 2.16M | -2.25M | 636K | -843K | -514K | 857K | -1.38M | 1.42M | -1.51M | -2.1M | 9.17M | -6.72M |
| Change in Receivables | -94.84K | -476.47K | 0 | -744K | 952K | -576K | -226K | 0 | -477K | 688K | 1.69M | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.96M | 450.35K | 0 | -1.95M | 362K | 843K | -1.06M | 0 | 127K | 987K | -756K | 0 |
| Cash from Investing | -300K | -1.52K | 300K | 0 | -320K | 0 | 0 | 1K | -700K | 0 | 0 | 0 |
| Capital Expenditures | -299.5K | -1.52K | 0 | 0 | -20K | 0 | 0 | 0 | -700K | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -503 | 0 | 300K | 0 | -300K | 0 | 0 | 1K | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 38.73K | 0 | -134K | 422K | -40K | -594K | 46.78M | 0 | 0 | 7.91M | 67K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.9M | 0 |
| Equity Issued (Net) | 0 | 38.73K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.61M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | -134K | 422K | -40K | -594K | 46.78M | 0 | 0 | -796.05K | 67K |
| Net Change in Cash | -4.77M | -7.71M | -7.43M | -6.36M | -7.32M | -10.72M | -6.91M | 38.77M | -8.76M | -5.11M | 9.56M | -6.84M |
| Free Cash Flow | -4.31M | -7.68M | -7.31M | -7.65M | -8.65M | -9.42M | -7.52M | -7.9M | -8.69M | -6.79M | 2.66M | -7.75M |
| FCF Margin % | - | - | - | -1530.2% | - | - | - | - | - | -678.9% | 498.47% | -86.16% |
| FCF Growth % | 50.14% | 18.43% | 2.79% | 3.2% | 0.48% | -38.75% | -382.78% | -1.93% | 10.1% | 67.07% | 119.08% | 67.91% |
| FCF per Share | -0.03 | -0.05 | -0.05 | -0.05 | -0.06 | -0.06 | -0.05 | -0.06 | -0.06 | -0.05 | 0.02 | -0.06 |
| FCF Conversion (FCF/Net Income) | 0.64x | 1.05x | 1.04x | 0.52x | 0.65x | 1.35x | 0.50x | 0.64x | 0.89x | 0.75x | -0.41x | 4.43x |
| Interest Paid | 0 | 0 | 0 | 7K | 7K | 11K | 0 | 6K | 4K | 0 | 4K | 183K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |